# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Hemophagocytic Lymphohistiocytosis (HLH)

Hemophagocytic lymphohistiocytosis
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 21-23 of 23 results.
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Status: Recruiting
Last Changed: Jan 07, 2020
First Received: Jul 27, 2012
Disease(s): SCID, Omenn's Syndrome, Reticular Dysgenesis, Wiskott-Aldrich Syndrome, Bare Lymphocyte Syndrome, Common Variable Immunodeficiency, Chronic Granulomatous Disease, CD40 Ligand Deficiency, Hyper IgM Syndrome, X-linked Lymphoproliferative Disease, Hemophagocytic Lymphohistiocytosis, Griscelli Syndrome, Chediak-Higashi Syndrome, Langerhan's Cell Histiocytosis
Intervention(s): Alemtuzumab 0.3 mg, Cyclophosphamide, Busulfan, Stem Cell Transplantation, Fludarabine phosphate 40 mg, Melphalan, Alemtuzumab 0.2 mg, Busulfan, Fludarabine phosphate 30 mg, MESNA
Locations: Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Status: Recruiting
Last Changed: Oct 24, 2019
First Received: Oct 14, 2013
Disease(s): Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD), Hereditary Anemias, Inflammatory Conditions
Intervention(s): Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa
Locations: Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Status: Recruiting
Last Changed: Jan 27, 2020
First Received: Jun 12, 2009
Disease(s): Non-Neoplastic Hematologic and Lymphocytic Disorder
Intervention(s): Allogeneic Bone Marrow Transplantation, Anti-Thymocyte Globulin, Cyclosporine, Fludarabine Phosphate, Laboratory Biomarker Analysis, Methotrexate, Mycophenolate Mofetil, Peripheral Blood Stem Cell Transplantation, Tacrolimus, Total-Body Irradiation, Treosulfan, Umbilical Cord Blood Transplantation
Locations: Children's Hospital Colorado, Aurora, Colorado, United States
Oregon Health and Science University, Portland, Oregon, United States
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Seattle Children's Hospital, Seattle, Washington, United States
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
... and 2 other locations.